|
Volumn 14, Issue 11, 2013, Pages 1104-1107
|
HIV-AIDS: Much accomplished, much to do
|
Author keywords
[No Author keywords available]
|
Indexed keywords
ANTIRETROVIRUS AGENT;
CD4 ANTIGEN;
EMTRICITABINE PLUS TENOFOVIR DISOPROXIL;
HUMAN IMMUNODEFICIENCY VIRUS VACCINE;
ACQUIRED IMMUNE DEFICIENCY SYNDROME;
AIDS PATIENT;
CD4+ T LYMPHOCYTE;
CIRCUMCISION;
HIGH RISK POPULATION;
HUMAN;
HUMAN IMMUNODEFICIENCY VIRUS INFECTED PATIENT;
HUMAN IMMUNODEFICIENCY VIRUS INFECTION;
IMMUNE RESPONSE;
INFECTION PREVENTION;
INFECTION RISK;
PANDEMIC;
PATIENT COMPLIANCE;
PRIORITY JOURNAL;
REVIEW;
VIRUS LOAD;
ACQUIRED IMMUNODEFICIENCY SYNDROME;
AIDS VACCINES;
ANTI-HIV AGENTS;
ANTIBODIES, NEUTRALIZING;
ANTIGENS, VIRAL;
ANTIRETROVIRAL THERAPY, HIGHLY ACTIVE;
HIV;
HUMANS;
PANDEMICS;
UNITED STATES;
|
EID: 84886676924
PISSN: 15292908
EISSN: 15292916
Source Type: Journal
DOI: 10.1038/ni.2735 Document Type: Review |
Times cited : (36)
|
References (27)
|